4D Molecular Therapeutics, Inc. (FDMT)
4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical trials: 4D-125 that is in a Phase 1/2 clinical trial for the treatment of X-linked retinitis pigmentosa; 4D-110 that is in a Phase 1/2 clinical trial for the treatment of choroideremia; and 4D-310, which is in a Phase 1/2 clinical trial for the treatment of Fabry disease. Its two IND candidates are 4D-150 for the treatment of wet age-related macular degeneration and 4D-710 for the treatment of cystic fibrosis lung disease. 4D Molecular Therapeutics, Inc. has research and collaboration arrangements with uniQure; CRF; Roche; and CFF. The company was founded in 2013 and is headquartered in Emeryville, California.4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical trials: 4D-125 that is in a Phase 1/2 clinical trial for the treatment of X-linked retinitis pigmentosa; 4D-110 that is in a Phase 1/2 clinical trial for the treatment of choroideremia; and 4D-310, which is in a Phase 1/2 clinical trial for the treatment of Fabry disease. Its two IND candidates are 4D-150 for the treatment of wet age-related macular degeneration and 4D-710 for the treatment of cystic fibrosis lung disease. 4D Molecular Therapeutics, Inc. has research and collaboration arrangements with uniQure; CRF; Roche; and CFF. The company was founded in 2013 and is headquartered in Emeryville, California.
$783.18M
Dr. David H. Kirn M.D.
140.00
EmeryVille, CA
Dec 11, 2020
-6.79
$-2.22
16.80
32.65
-511.23%
-8.45
-0.23
1.47
45.35
32.06
-16.60%
-48.32%
Similar stocks (15)
Revolution Medicines, Inc.
RVMD
Akero Therapeutics, Inc.
AKRO
Edgewise Therapeutics, Inc.
EWTX
Cullinan Oncology, Inc.
CGEM
Stoke Therapeutics, Inc.
STOK
Replimune Group, Inc.
REPL
C4 Therapeutics, Inc.
CCCC
Black Diamond Therapeutics, Inc.
BDTX
Biomea Fusion, Inc.
BMEA
Gossamer Bio, Inc.
GOSS
Century Therapeutics, Inc.
IPSC
Nuvectis Pharma, Inc.
NVCT
Kronos Bio, Inc.
KRON
Passage Bio, Inc.
PASG
Lyra Therapeutics, Inc.
LYRA
ETF Exposure (43)
Franklin Genomic Advancements ETF
HELX
0.81%
iShares Genomics Immunology and Healthcare ETF
IDNA
0.75692%
iShares Micro-Cap ETF
IWC
0.20709%
SPDR S&P Biotech ETF
XBI
0.207076%
Direxion Daily S&P Biotech Bull 3X Shares
LABU
0.1451915958%
BlackRock Future Health ETF
BMED
0.08795%
Invesco Nasdaq Biotechnology ETF
IBBQ
0.08%
SPDR S&P Kensho New Economies Composite ETF
KOMP
0.067988%
iShares Biotechnology ETF
IBB
0.06435%
Vanguard U.S. Momentum Factor ETF
VFMO
0.05%
Vanguard Russell 2000 Growth Index Fund
VTWG
0.04%
iShares Russell 2000 Growth ETF
IWO
0.0391%
iShares Russell 2000 ETF
IWM
0.03014%
Vanguard Russell 2000 Index Fund
VTWO
0.03%
Schwab U.S. Small-Cap ETF
SCHA
0.0234991041%
ProShares Ultra Nasdaq Biotechnology
BIB
0.023129742513393257%
iShares Russell 2000 Value ETF
IWN
0.02129%
Vanguard Russell 2000 Value Index Fund
VTWV
0.02%
ProShares Ultra Russell2000
UWM
0.011446850738937885%
Vanguard Health Care Index Fund
VHT
0.01%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0.01%
Vanguard Extended Market Index Fund
VXF
0.01%
Fidelity MSCI Health Care Index ETF
FHLC
0.0069409%
ProShares UltraPro Russell2000
URTY
0.005642323743225085%
ALPS Medical Breakthroughs ETF
SBIO
0.0056%
ProShares Hedge Replication ETF
HDG
0.004788983979705789%
Dimensional U.S. Core Equity 2 ETF
DFAC
0.00455609%
Dimensional U.S. Small Cap ETF
DFAS
0.00410344%
SPDR Portfolio MSCI Global Stock Market ETF
SPGM
0.002704%
Schwab U.S. Broad Market ETF
SCHB
0.0014833197%
Dimensional US Core Equity Market ETF
DFAU
0.00145804%
iShares Russell 3000 ETF
IWV
0.00136%
iShares Core S&P Total U.S. Stock Market ETF
ITOT
0.00131%
Dimensional U.S. Equity ETF
DFUS
5.436e-4%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Similar stocks (15)
Revolution Medicines, Inc.
RVMD
Akero Therapeutics, Inc.
AKRO
Edgewise Therapeutics, Inc.
EWTX
Cullinan Oncology, Inc.
CGEM
Stoke Therapeutics, Inc.
STOK
Replimune Group, Inc.
REPL
C4 Therapeutics, Inc.
CCCC
Black Diamond Therapeutics, Inc.
BDTX
Biomea Fusion, Inc.
BMEA
Gossamer Bio, Inc.
GOSS
Century Therapeutics, Inc.
IPSC
Nuvectis Pharma, Inc.
NVCT
Kronos Bio, Inc.
KRON
Passage Bio, Inc.
PASG
Lyra Therapeutics, Inc.
LYRA
ETF Exposure (43)
Franklin Genomic Advancements ETF
HELX
0.81%
iShares Genomics Immunology and Healthcare ETF
IDNA
0.75692%
iShares Micro-Cap ETF
IWC
0.20709%
SPDR S&P Biotech ETF
XBI
0.207076%
Direxion Daily S&P Biotech Bull 3X Shares
LABU
0.1451915958%
BlackRock Future Health ETF
BMED
0.08795%
Invesco Nasdaq Biotechnology ETF
IBBQ
0.08%
SPDR S&P Kensho New Economies Composite ETF
KOMP
0.067988%
iShares Biotechnology ETF
IBB
0.06435%
Vanguard U.S. Momentum Factor ETF
VFMO
0.05%
Vanguard Russell 2000 Growth Index Fund
VTWG
0.04%
iShares Russell 2000 Growth ETF
IWO
0.0391%
iShares Russell 2000 ETF
IWM
0.03014%
Vanguard Russell 2000 Index Fund
VTWO
0.03%
Schwab U.S. Small-Cap ETF
SCHA
0.0234991041%
ProShares Ultra Nasdaq Biotechnology
BIB
0.023129742513393257%
iShares Russell 2000 Value ETF
IWN
0.02129%
Vanguard Russell 2000 Value Index Fund
VTWV
0.02%
ProShares Ultra Russell2000
UWM
0.011446850738937885%
Vanguard Health Care Index Fund
VHT
0.01%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0.01%
Vanguard Extended Market Index Fund
VXF
0.01%
Fidelity MSCI Health Care Index ETF
FHLC
0.0069409%
ProShares UltraPro Russell2000
URTY
0.005642323743225085%
ALPS Medical Breakthroughs ETF
SBIO
0.0056%
ProShares Hedge Replication ETF
HDG
0.004788983979705789%
Dimensional U.S. Core Equity 2 ETF
DFAC
0.00455609%
Dimensional U.S. Small Cap ETF
DFAS
0.00410344%
SPDR Portfolio MSCI Global Stock Market ETF
SPGM
0.002704%
Schwab U.S. Broad Market ETF
SCHB
0.0014833197%
Dimensional US Core Equity Market ETF
DFAU
0.00145804%
iShares Russell 3000 ETF
IWV
0.00136%
iShares Core S&P Total U.S. Stock Market ETF
ITOT
0.00131%
Dimensional U.S. Equity ETF
DFUS
5.436e-4%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%